Andréa Stinghen Universidade Federal do ParanáBrazil

Andréa E. M. Stinghen, has PhD in Health Sciences (NEPHROLOGY) at Pontifícia Universidade Católica do Paraná and Post-Doctorate at Université de Picardie Jules Verne, France (UREMIC TOXICITY), Master in Pharmaceutical Sciences at Universidade Federal do Paraná. Under graduation in Pharmacy and Biochemistry at Universidade Federal do Paraná. He is currently Associate professor at Department of Basic Pathology in Universidade Federal do Paraná. Coordinates the Experimental Nephrology Laboratory where develops research in cellular and molecular mechanisms of uremic toxicity.

1 APRIL 2023

Time Session
17:00
18:00
*This session is for In-Person delegates only
Poster session 2
  • Acid-base and Electrolyte Abnormalities in Kidney Disease
    Andréa Stinghen Moderator Universidade Federal do ParanáBrazil
  • Acute Kidney Injury Clinical, Drugs, AKI-CKD Continuum 2
    Rolando Claure-Del Granado Moderator Hospital Obrero No 2 - C.N.S.Bolivia
  • Chronic Kidney Disease Complications (CVD, Hypertension, Anemia, BMD, Nutrition, Infection) 3
    Kraiwiporn KIATTISUNTHORN Moderator Siriraj HospitalThailand
  • Chronic Kidney Disease Diagnosis, Classification and Progression 2
    Richard Kitching Moderator Monash University, Monash Medical CenterAustralia
  • Chronic Kidney Disease, Experimental Models, Biomarkers, Precision Medicine 2
    Wenjun Ju Moderator wenjunj@med.umich.eduUniversity Of Michigan Medical CenterUnited States
  • Clinical Glomerulonephritis 3
    Hernan Trimarchi Moderator HOSPITAL BRITANICO DE BUENOS AIRESArgentina
  • Covid-19 and CKD
    Opeyemi Olabisi Moderator Duke UniversityUnited States
  • Curriculum
    Prapaipim Thirakhupt Moderator prapaipimt@yahoo.com
  • Diabetic Kidney Disease, Drugs and Treatments 2
    Dr Giorgina Barbara Piccoli Moderator gpiccoli@ch-lemans.frCHM Le MansFrance
  • Epidemiology, Outcomes and Health Service Research Related to CKD or Its Complications 2
    Sabine Karam Moderator Saint George Hospital University Medical CenterLebanon
  • Epidemiology, Outcomes and Health Services Research in Dialysis 2
    Ana Elizabeth Figueiredo Moderator anaef@pucrs.brBrazil
  • Essential Hypertension and Renovascular Kidney Disease
    Barry Freedman Moderator Wake Forest University School of Medicine United States
  • Genetics and Epigenetics (Including Common and Rare Genetic Diseases)
    Chairat Shayakul Moderator Faculty of Medicine Siriraj Hospital, THAILANDThailand
  • Haemodialysis, Haemodiafiltration and Vascular Access 2
    Brendan Smyth Moderator St George HospitalAustralia
  • Haemodialysis, Haemodiafiltration and Vascular Access 3
    Jonathan Himmelfarb Moderator jhimmelfarb@nephrology.washington.eduKidney Research Institute, University of Washington United States
  • Inflammation, Fibrosis, Matrix Biology and Oxidative Stress
    Youhua LIU Moderator University of PittsburghUnited States
  • Kidney Transplantation and Transplant Immunology 3
    Narayan Prasad Moderator Sanjay Gandhi Post Graduate Institute of Medical SIndia
  • Kidney Transplantation and Transplant Immunology 4
    Professor Yingyos Avihingsanon Moderator yingyos@hotmail.com
  • Late Breaking Clinical Trials
    Muh Geot Wong Moderator University of SydneyAustralia
  • Nephrotic Syndrome
    Alessia Fornoni Moderator University of MiamiUnited States
  • Other CKD 2
    Jie Dong Moderator jie.dong@bjmu.edu.cnPeking University First HospitalChina
  • Other KF (Kidney Failure)
    Tai Shuan Lai Moderator National Taiwan University HospitalTaiwan
  • Peritoneal Dialysis 2
    Piyatida Chuengsaman Moderator Thailand
  • Peritoneal Dialysis 3
    Afiatin Abdurahman Moderator
  • Training
    Naowanit Nata Moderator
  • Tropical Kidney Diseases (Viral Nephropathies, TB, Schistosomiasis, Malaria, Leptospirosis, Animal Venoms)
    Opas Traitanon Moderator
  • Urologic Disorders
    Sritippayawan Suchai Moderator Siriraj Hospital Thailand
  • Vascular Biology and Endothelial Function
    Reiko Inagi Moderator Univ of Tokyo - Grad. School of MedicineJapan
Ballroom 2-3-4-Exhibition Hall

31 MARCH 2023

Time Session
11:45
12:45
The Spectrum of Uremic Toxicity
Paweena Susantitaphong Chairperson pesancerinus@hotmail.comKing Chulalongkorn Memorial HospitalThailand
Sanjin Racki Chairperson KBC RijekaCroatia
  • Gut-derived Uremic Toxins
    Paweena Susantitaphong Speaker pesancerinus@hotmail.comKing Chulalongkorn Memorial HospitalThailand
  • Uremic Toxins and Peripheral Artery Disease
    Vipul Chitalia Speaker Renal SectionUnited States
  • Uremic Toxins and Endothelium
    Andréa Stinghen Speaker Universidade Federal do ParanáBrazil
  • Q and A
MR 111
14:15
15:15
Kidney Failure and Mineral Bone Disease
Andréa Stinghen Chairperson Universidade Federal do ParanáBrazil
Boon Wee Teo Chairperson mdctbw@nus.edu.sgNational University of SingaporeSingapore
  • Making Sense of the Current Guidelines on BMD
    Wei Chen Speaker vvchen66@qq.comThe First Affiliated Hospital, Sun Yat-sen University China
  • Is it Enough to Target the CaSR ?
    Ziad Massy Speaker Univ Hospital Ambroise ParéFrance
  • The Role of PO4 and PTH in Vascular Calcification
    Sinee Disthabanchong Speaker Faculty of Medicine, Ramathibodi Hospital, Mahidol UniversityThailand
  • Q and A
MR 111